Cardiovascular Risk Markers TRIUMPH-4 also assessed a panel of cardiometabolic biomarkers, and the results were broadly favorable across the board: Non-HDL cholesterol significant reductions, indicating improved atherogenic lipid burden Triglycerides meaningful decreases, consistent with the known effects of GLP-1 and GIP receptor activation on lipid metabolism High-sensitivity C-reactive protein (hsCRP) substantial reductions, reflecting decreased systemic inflammation
Prioritizing protein helps preserve (or grow) lean muscle mass (especially important on a calorie reduction), maintain strength, and support healthy aging during weight loss
The muscle-preserving effect of resistance training becomes increasingly important as weight loss progresses
While tirzepatide will not affect drug screening results, accurate medication disclosure supports comprehensive care, appropriate risk assessment, and optimal clinical decision-making
In laboratory studies, Retatrutide is investigated for its potential to modulate biological signaling through simultaneous engagement of three receptor pathways: the glucagon-like peptide-1 receptor (GLP-1R), the glucose-dependent insulinotropic polypeptide receptor (GIPR), and the glucagon receptor (GCGR)
Did I use Ozempic or Zepbound
